The Latest Headlines at Community Financial News
Insider Buying: Galan Lithium Limited (ASX:GLN) Insider Buys 50,000 Shares of Stock
Galan Lithium Limited (ASX:GLN) insider Terry Gardiner purchased 50,000 shares of the stock in a transaction that occurred on Friday, September 17th. The stock was bought at an average cost of A$0.25 ($0.18) per share, with a total... More of this article »
Picton Mahoney Asset Management Invests $802,000 in Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ)
Picton Mahoney Asset Management acquired a new position in shares of Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) in the 2nd quarter, HoldingsChannel reports. The institutional investor acquired 78,507 shares of the company’s... More of this article »
Analysts Expect iTeos Therapeutics, Inc. (NASDAQ:ITOS) to Post $4.95 EPS
Wall Street brokerages forecast that iTeos Therapeutics, Inc. (NASDAQ:ITOS) will report earnings per share (EPS) of $4.95 for the current fiscal quarter, according to Zacks. Two analysts have made estimates for iTeos Therapeutics’... More of this article »
Picton Mahoney Asset Management Purchases Shares of 50,000 Social Capital Hedosophia Holdings Corp. IV (NYSE:IPOD)
Picton Mahoney Asset Management acquired a new position in Social Capital Hedosophia Holdings Corp. IV (NYSE:IPOD) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional... More of this article »
abrdn plc Invests $1.17 Million in Unity Software Inc. (NYSE:U)
abrdn plc acquired a new position in Unity Software Inc. (NYSE:U) during the 2nd quarter, HoldingsChannel.com reports. The firm acquired 10,669 shares of the company’s stock, valued at approximately $1,172,000. Other institutional... More of this article »
abrdn plc Has $1.27 Million Stake in GoDaddy Inc. (NYSE:GDDY)
abrdn plc trimmed its position in GoDaddy Inc. (NYSE:GDDY) by 17.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,598 shares of... More of this article »
Accenture (NYSE:ACN) Given New $354.00 Price Target at Piper Sandler
Accenture (NYSE:ACN) had its price target boosted by Piper Sandler from $302.00 to $354.00 in a research note released on Friday, The Fly reports. Piper Sandler currently has a neutral rating on the information technology services... More of this article »
Performance Food Group (NYSE:PFGC) Shares Sold by abrdn plc
abrdn plc lowered its stake in Performance Food Group (NYSE:PFGC) by 95.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 27,958 shares of the food distribution... More of this article »
abrdn plc Has $1.49 Million Position in Jabil Inc. (NYSE:JBL)
abrdn plc lowered its holdings in shares of Jabil Inc. (NYSE:JBL) by 2.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,603... More of this article »
Insider Selling: Ciena Co. (NYSE:CIEN) SVP Sells $159,311.79 in Stock
Ciena Co. (NYSE:CIEN) SVP Jason Phipps sold 3,069 shares of the firm’s stock in a transaction dated Tuesday, September 21st. The shares were sold at an average price of $51.91, for a total transaction of $159,311.79. The sale... More of this article »
ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) Expected to Announce Earnings of -$0.12 Per Share
Wall Street brokerages expect ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) to post earnings per share (EPS) of ($0.12) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have made estimates for ASLAN... More of this article »
FedEx (NYSE:FDX) Lowered to Market Perform at Raymond James
Raymond James lowered shares of FedEx (NYSE:FDX) from an outperform rating to a market perform rating in a research note released on Wednesday morning, PriceTargets.com reports. FDX has been the topic of a number of other reports.... More of this article »
-$0.49 Earnings Per Share Expected for Omega Therapeutics Inc (NASDAQ:OMGA) This Quarter
Equities research analysts expect that Omega Therapeutics Inc (NASDAQ:OMGA) will report earnings per share of ($0.49) for the current quarter, according to Zacks Investment Research. Zero analysts have made estimates for Omega Therapeutics’... More of this article »